For help on how to get the results you want, see our search tips.
8652 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Lantus (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 09/06/2000, Revision: 36, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 10, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)
daptomycin, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 22/03/2017,, Revision: 10, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Nucala (updated)
Mepolizumab, Asthma
Date of authorisation: 01/12/2015, Revision: 14, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Velcade (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 26/04/2004, Revision: 44, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Flixabi (updated)
infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 26/05/2016,,
, Revision: 16, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Qutenza (updated)
capsaicin, Neuralgia
Date of authorisation: 15/05/2009, Revision: 15, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Karvezide (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 16/10/1998, Revision: 40, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Topotecan Hospira (updated)
topotecan, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 09/06/2010, Revision: 16, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018,,
, Revision: 11, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Stelara (updated)
Ustekinumab, Psoriasis, Arthritis, Psoriatic, Crohn Disease
Date of authorisation: 15/01/2009, Revision: 34, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Orfadin (updated)
nitisinone, Tyrosinemias
Date of authorisation: 20/02/2005, Revision: 20, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Epidyolex (updated)
Cannabidiol, Lennox Gastaut Syndrome, Epilepsies, Myoclonic
Date of authorisation: 19/09/2019,, Revision: 5, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Repatha (updated)
Evolocumab, Dyslipidemias, Hypercholesterolemia
Date of authorisation: 17/07/2015, Revision: 16, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 11, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Braftovi (updated)
Encorafenib, Melanoma, Colorectal Neoplasms
Date of authorisation: 19/09/2018,, Revision: 5, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Gencebok (updated)
Caffeine citrate, Apnea
Date of authorisation: 19/08/2020, Revision: 2, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Aubagio (updated)
Teriflunomide, Multiple Sclerosis
Date of authorisation: 26/08/2013, Revision: 17, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Eylea (updated)
aflibercept, Wet Macular Degeneration, Macular Edema, Diabetes Complications
Date of authorisation: 21/11/2012, Revision: 20, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ondexxya (updated)
andexanet alfa, Drug-Related Side Effects and Adverse Reactions
Date of authorisation: 26/04/2019,,
, Revision: 8, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Karvea (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 40, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Glivec (updated)
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001,, Revision: 40, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): CoAprovel (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 14/10/1998, Revision: 41, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Byetta (updated)
exenatide, Diabetes Mellitus, Type 2
Date of authorisation: 20/11/2006, Revision: 24, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Praluent (updated)
Alirocumab, Dyslipidemias
Date of authorisation: 23/09/2015, Revision: 16, Authorised, Last updated: 01/03/2021